Rages and refusals: Managing the many faces of adolescent anxiety

Canadian Family Physician

Volumn 47, Issue MAY, 2001, Pages 1023-1030

  Garland, E Jane ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE; BRONCHODILATING AGENT; BUSPIRONE; CAFFEINE; CANNABIS; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENCE; ADOLESCENT; ANORGASMIA; ANXIETY NEUROSIS; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DRUG EFFICACY; DRUG INDUCED DISEASE; FAMILY MEDICINE; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; RAGE; REVIEW; SCHOOL; SUBSTANCE ABUSE; TREATMENT INDICATION;

ADOLESCENT; ANXIETY DISORDERS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; COMORBIDITY; FAMILY PRACTICE; HUMANS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SOCIAL BEHAVIOR DISORDERS;

EID: 0034972799     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Keller MB, Lavori PW, Wunder J, Beardslee WR, Schwartz CE, Roth J. Chronic course of anxiety disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry 1992;31:595-9.
2. Bernstein GA, Borchardt CM, Perwein AR. Anxiety disorders in children and adolescents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1996;35:1110-9.
3. Stein DJ, Bouwer C. A neuro-evolutionary approach to the anxiety disorders. J Anxiety Disord 1997;11:409-29.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
5. Bernstein GA, Shaw K. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997;36(Suppl 10):69S-84S.
6. Black B. Separation anxiety disorder and panic disorder. In: March JS, editor. Anxiety disorders in children and adolescents. New York, NY: The Guildford Press, 1995. p. 212-34.
7. Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, et al. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 1994;33:782-91.
8. Costello EJ, Angold A. Epidemiology. In: March JS, editor. Anxiety disorders in children and adolescents. New York, NY: The Guildford Press; 1995. p. 109-24.
9. Moreau D, Follett C. Panic disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1993;2:581-602.
10. Friman PC, Lucas CP. Social phobia obscured by disruptive behavior disorder. A case study. Clin Child Psychol Psychiatry 1996;1:399-407.
11. Frick PJ, Lilienfdd SO, Ellis M, Loney B, Silverthorn P. The association between anxiety and psychopathy dimensions in children. J Abnorm Child Psychol 1999;27:383-92.
12. Last CG, Hansen C, Franco N. Cognitive-behavioral treatment of school-phobia. J Am Acad Child Adolesc Psychiatry 1998;37:404-11.
13. Kushner MG, Sher KJ, Erickson DJ. Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am J Psychiatry 1999;156:723-32.
14. Zoccolillo M, Vitaro F, Tremblay RE. Problem drug and alcohol use in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 1999;38:900-7.
15. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 1999;141:395-404.
16. Wiesbeck GA, Schucki MA, Tipp JE, Bucholz KK, Smith TI. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 1996;91:1469-78.
17. Crowley TJ, Macdonald MJ, Whitmore EA, Miculich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance abuse disorders. Drug Alcohol Depend 1998;50:27-37.
18. Court JM. Cannabis and brain function. J Paediatr Child Health 1998;34:1-5.
19. Solowij N, Michie PT, Fox AM. Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 1995;37:731-9.
20. Pope HG, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38:25-34.
21. Garland EJ, Clark SL. Taming worry dragons. Vancouver, BC: Mood and Anxiety Disorders Clinic, British Columbia Children's Hospital; 1995.
22. Albano AM, Marten PA, Holt CS, Heimberg RG, Barlow DH. Cognitive-behavioral group treatment for social phobia in adolescents. A preliminary study. J Nerv Ment Dis 1995;183:649-56.
23. King NJ, Tonge BJ, Heyne D, Pritchard M, Rollongs S, Young D, et al. Cognitive-behavioral treatment of school-refusing children: a controlled evaluation. J Am Acad Child Adolesc Psychiatry 1998;37:395-403.
24. March JS. Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment. J Am Acad Child Adolesc Psychiatry 1995;34:7-18.
25. Hipp E. Fighting invisible tigers: a stress management guide for teens. Rev ed. Minneapolis. Minn: Free Spirit; 1995.
26. Carmin CN, Pollard CA, Flynn T, Markway B. Dying of embarrassment: help for social anxiety and phobia. Oakland, Calif: New Harbinger Public Inc; 1997.
27. Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychictr Scand 1997;95:444-50.
28. March JS, Leonard HL, Swedo SE. Pharmacotherapy of obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am 1995;4:217-36.
29. Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994;33:1000-6.
30. Kutcher S, Mackenzie S. Successful clonazepam treatment of adolescents with panic disorder. J Can Psychopharmacol 1988;8:299-301.
31. Reiter S, Kutcher S. Disinhibition and anger outbursts in adolescents treated with clonazepam. J Clin Psychopharmacol 1991;11:268.
32. Simeon JG, Knott VJ, Thatte S, Dubois CD, Wiggings DM, Geraets I. Pharmacotherapy of childhood anxiety disorders. Clin Neuropharmacol 1992;15(Suppl 1 Pt A):229A-30A.
33. Birmaher B, Waterman GS, Ryan N, Cully M, Balach L, Ingram J, et al. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994;33:993-9.
34. Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Chapell P, et al. Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1991;1:193-8.
35. Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J. Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders. J Am Acad Child Adolesc Psychiatry 1993;32:483-93.
36. Bernstein GA, Borschardt CM, Perwein AR, Crosby RD, Kushner MG, Thuras PD, et al. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 2000;39:276-83.
37. Otto MW, Whittal ML. Cognitive-behavior therapy and the longitudinal course of panic disorder. Psychiatr Clin North Am 1995;18:803-20.